Skip to main content

Table 2 Patient and tumour characteristics

From: Multidisciplinary first-day consultation accelerates diagnostic procedures and throughput times of patients in a head-and-neck cancer care pathway, a mixed method study

 

Pre-MFDC

Post-MFDC

Sign.

2007 (n = 21)

2008 (n = 20)

2010 (n = 24)

2013 (n = 24)

ANOVA

Age Mean(SD)

66

(11)

66

(13)

63

(13)

64

(9)

.640

 

Chi2

Gender

n

%

n

%

n

%

n

%

.680

 Male

14

67

13

65

18

75

14

58

 

Tumour localization

.303

 Lip

0

0

0

0

0

0

2

100

 

 Oral cavity

8

38

11

55

17

71

9

38

 

  Tongue (C01, C02)

3

 

2

 

6

 

1

  

  Gums (C03)

1

 

3

 

2

 

0

  

  Floor of mouth (C04)

3

 

4

 

4

 

6

  

  Oral cavity, unspec.

1

 

2

 

5

 

2

  

(C00, C05, C06, C14)

 Major salivary glands (C07, C08)

1

5

0

0

0

0

0

0

 

 Oropharynx (C09,C10)

2

10

2

10

1

4

4

17

 

 Nasopharynx (C11)

1

5

2

10

1

4

1

4

 

 Nasal Cavity (C30)

0

 

0

0

1

4

1

4

 

 Hypopharynx (C12, C13)

3

14

1

5

0

0

5

21

 

 Larynx (C32)

6

29

4

20

4

17

2

8

 

Tumour size

.522

 T1

9

43

8

40

10

42

4

17

 

 T2

5

24

4

20

5

21

6

26

 

 T3

3

14

2

10

3

13

2

8

 

 T4

4

19

6

30

5

21

12

50

 

 Tx

0

0

0

0

1

0

0

0

 
  1. In bold main patient characteristics of the dataset (age, gender, tumour localization and size)